Low-dose and high-dose aprotinin improve hemostasis in coronary operations
- 31 August 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 112 (2) , 523-530
- https://doi.org/10.1016/s0022-5223(96)70281-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Is there a phase of hypercoagulability when aprotinin is usedin cardiac surgery?European Journal of Cardio-Thoracic Surgery, 1994
- Reduction of heparin binding to and inhibition of platelets by aprotininThe Annals of Thoracic Surgery, 1993
- Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993
- High-dose aprotinin therapy: A review of the first five years' experienceJournal of Cardiothoracic and Vascular Anesthesia, 1992
- Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrateBiochemistry, 1991
- Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypassThe Annals of Thoracic Surgery, 1991
- Platelet preservation during cardiopulmonary bypass with aprotininEuropean Journal of Cardio-Thoracic Surgery, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Monitoring of aprotinin plasma levels by an enzyme-linked immunosorbent assay (ELISA)Analytical and Bioanalytical Chemistry, 1984